Inception Return
(11/4/2022)
|
-10.97 %
|
YTD Return
|
-2.76 %
|
|
NAVPS
(7/10/2025)
|
$7.36
|
Change
|
($0.01) / -0.17 %
|
|
Growth of $10,000
(As of June 30, 2025)
|
MER
|
1.97 %
|
Assets ($mil)
|
$5.17
|
Rank (1Yr)
|
5/55
|
Std Dev (3Yr)
|
-
|
Volatility Ranking (3Yr)
|
-
|
RRSP Eligibility
|
Yes
|
Load
|
Back Fee Only
|
Max Front End
|
5.00 %
|
Max Back End
|
-
|
Sales Status
|
Open
|
|
Objective
This fund’s objective is to provide long-term capital growth by investing primarily in equity securities of companies involved in disruptive genomic innovation from around the world.
|
Fund Manager
BMO Investments Inc.
Portfolio Manager
Nicholas Grous, Ark Investment Management LLC
Dan White, Ark Investment Management LLC
Catherine D. Wood, Ark Investment Management LLC
Sub-Advisor
-
|
Asset Allocation
(As of June 30, 2025)
|
Sector Allocation
(As of June 30, 2025)
|
Geographic Allocation
(As of June 30, 2025)
|
Top 10 Holdings
Name | Asset | Sector | Geographic | Percent |
CRISPR Therapeutics AG | International Equity | Healthcare | Other European | 9.61% |
Tempus AI Inc Cl A | US Equity | Healthcare | United States | 9.27% |
Twist Bioscience Corp | US Equity | Healthcare | United States | 7.37% |
Guardant Health Inc | US Equity | Healthcare | United States | 6.59% |
Recursion Pharmaceuticals Inc Cl A | US Equity | Healthcare | United States | 5.56% |
Natera Inc | US Equity | Healthcare | United States | 5.32% |
Adaptive Biotechnologies Corp | US Equity | Healthcare | United States | 4.39% |
Personalis Inc | US Equity | Healthcare | United States | 4.37% |
CareDx Inc | US Equity | Healthcare | United States | 3.85% |
Schrodinger Inc | US Equity | Technology | United States | 3.77% |
Performance Data
(As of June 30, 2025)
|
Return (%)
|
Annualized Return (%)
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
Fund
|
14.96
|
10.37
|
-2.76
|
-2.76
|
1.98
|
-
|
-
|
-
|
Benchmark
|
0.91
|
-7.89
|
-3.97
|
-3.97
|
-4.44
|
5.66
|
5.14
|
7.26
|
Quartile Ranking
|
1
|
1
|
1
|
1
|
1
|
-
|
-
|
-
|
Calendar Return (%)
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
Fund
|
-22.40
|
11.86
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Benchmark
|
9.95
|
1.42
|
-1.72
|
15.28
|
13.59
|
17.06
|
11.82
|
14.01
|
-8.68
|
27.73
|
Quartile Ranking
|
4
|
1
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|